Market Cap

Tilray, Inc. Market Capitalization:

$1.69 Billion

USD as of Jan. 1, 2024

business Tilray, Inc. Company Profile

Tilray, Inc. Main Stock Listing

NASDAQ: TLRY

Market Capitalization History of Tilray, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Tilray, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $1.69 B -1.11%
Jan. 1, 2023 $1.71 B -50.39%
Jan. 1, 2022 $3.44 B -67.07%
Jan. 1, 2021 $10.44 B 3.19%
Jan. 1, 2020 $10.12 B -78.21%
Jan. 1, 2019 $46.43 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Tilray, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Tilray, Inc. has the following listings and related stock indices.


Stock: NASDAQ: TLRY

Stock: FSX: 2HQ

Stock: TSX: TLRY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.